September 2025—Copan Diagnostics has appointed Hema Kapoor, MD, D(ABMM), as director of medical and scientific affairs for the Americas, succeeding Susan Sharp, PhD, D(ABMM), who will retire this month following more than three decades of distinguished service to clinical microbiology.
Dr. Sharp joined Copan in 2018, after a career spanning more than 30 years as a clinical microbiologist, educator, and industry leader. She previously served as chief of microbiology at Kaiser Permanente and held leadership roles at the American Society for Microbiology, including chair of the committee on laboratory practices and past president. A diplomate of the American Board of Medical Microbiology and fellow of the American Academy of Microbiology, Dr. Sharp has been recognized with ASM’s highest clinical honor, the BioMérieux Sonnenwirth Award, and the ABMM Professional Recognition Award. At Copan, her leadership has been defined by keen insight and a steadfast advocacy for advancing microbiology.
“Dr. Sharp’s contributions to microbiology and Copan have been immeasurable,” Fabrizio Mazzocchi, CEO of Copan, said in a press statement. “We are deeply grateful for her leadership and are excited to welcome Dr. Kapoor, whose global perspective and expertise will help shape our next chapter of scientific innovation.”
Dr. Kapoor brings more than two decades of experience in clinical diagnostics, infectious diseases, and medical affairs. Before joining Copan, Dr. Kapoor spent nearly 20 years at Quest Diagnostics, most recently as senior medical director of medical affairs, where she led scientific strategy for infectious diseases and immunology. During the COVID-19 pandemic, she led national preparedness efforts and was recognized by the Gold Foundation for her outstanding leadership. Dr. Kapoor is a diplomate of the ABMM and an ASCP-certified specialist in microbiology, with postdoctoral training at both Mayo Clinic and All India Institute of Medical Sciences. Her background spans hospital microbiology, laboratory operations, research and development, and health equity initiatives.
In her new role, Dr. Kapoor will oversee Copan’s scientific and medical strategy in the Americas, foster collaborative research, and continue the company’s mission of delivering high-quality, evidence-based solutions for the laboratory community.